NEKTAR THERAPEUTICS - 8-K Filing
Nektar Therapeutics reports $952.9 million in cash and investments with a projected runway into Q3 2028. (Items: 7.01 Regulation FD)
Tickers: $NKTR
More Regulatory news
- Nova Minerals Corp - 8-K Filing
- Vertiv Holdings Co - 8-K Filing
- Rezolute, Inc. - 8-K Filing
- REGIONAL HEALTH PROPERTIES, INC - 10-Q Filing
- BLUE BIOFUELS, INC. - 10-Q Filing
- First Choice Healthcare Solutions, Inc. - 10-Q Filing
- OpenWorld, Inc. - 10-Q Filing
- Weatherford International Corp - 8-K Filing
- iRhythm Holdings, Inc. - 8-K Filing
- King Resources Global, Inc. - 10-Q Filing